Suppression of laser-induced choroidal neovascularization by posterior sub-tenon administration of triamcinolone acetonide

Retina

Volumn 25, Issue 4, 2005, Pages 503-509

  Kato, Aki ^a   Kimura, Hideya ^a   Okabe, Komei ^a   Okabe, Junko ^a   Kunou, Noriyuki ^a   Nozaki, Miho ^a   Ogura, Yuichiro ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Choroidal Neovascularization; Sub Tenon injection; Triamcinolone acetonide

Indexed keywords

FLUORESCEIN; KENAKORT A; SODIUM CHLORIDE; TRIAMCINOLONE ACETONIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOROID; CONTROLLED STUDY; EVALUATION; FLUORESCENCE ANGIOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; LASER; LASER COAGULATION; MALE; NONHUMAN; RAT; RETINA; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VITREOUS BODY;

ANIMALS; CAPILLARY PERMEABILITY; CHOROIDAL NEOVASCULARIZATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CONNECTIVE TISSUE; DISEASE MODELS, ANIMAL; FLUORESCEIN ANGIOGRAPHY; GLUCOCORTICOIDS; LASER COAGULATION; MALE; RATS; RATS, INBRED BN; TRIAMCINOLONE ACETONIDE;

EID: 20344374629     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200506000-00017     Document Type: Article

References (51)

1. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration:updated findings from two clinical trials. Arch Ophthalmol 1993;111:1200-1209.
2. Macular Photocoagulation Study Group. Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration: the influence of initial lesion size and initial visual acuity. Arch Ophthalmol 1994;112:480-488.
3. Macular Photocoagulation Study Group. Persistent and recurrent neovascularization after laser photocoagulation for subfoveal choroidal neovascularization of age-related macular degeneration. Arch Ophthalmol 1994;112:489-499.
4. Ormerd LD, Puklin JE, Frank RN. Long-term outcomes after the surgical removal of advanced subfoveal neovascular membranes in age-related macular degeneration. Ophthalmology 1994;101:1201-1201.
5. Sakai K, Murata R, Mandai M, et al. Radiation therapy for ocular choroidal neovascularization (phase I/II study): preliminary report. Int J Radiat Oncol Biol Phys 1997;39:173-178.
6. Thomas MA, Dickinson JD, Melberg NS, et al. Visual results after surgical removal of subfoveal choroidal neovascular membranes. Ophthalmology 1994;101:1384-1396.
7. Bergink GJ, Hoyng CB, Van Der Maazen RWM, et al. Visual acuity and scar size in eyes with age-related subfoveal choroidal neovascular lesions, 30 months after radiation therapy. Doc Ophthalmol 1996;92:61-275.
8. Vatruba M, Gregor Z. Neovascular age-related macular degeneration: present and future treatment options. Eye 2001; 15:424-429.
9. Harding S. Photodynamic therapy in the treatment of subfoveal choroidal neovascularisation. Eye 2001;15:407-412.
10. American Academy of Ophthalmology. Photodynamic therapy with verteporfin for age-related macular degeneration. Ophthalmology. 2000;107:2314-2317.
11. Bressler NM. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Arch Ophthalmol 2001;119:198-207.
12. Tsujikawa M, Sawa M, Lewis J, et al. Choroidal damage caused by the excision of choroidal neovascularization. Am J Ophthalmol 1998;126:348-357.
13. Tanner V, Kanski JJ, Frith PA. Posterior sub-tenon's triamcinolone injections in the treatment of uveitis. Eye 1998;12: 679-685.
14. Tomsak RL, Lystad LD, Katirji MB et al. Rapid response of syphilitic optic neuritis to posterior sub-tenon's steroid injection. J Clin Neuro-ophthalmol 1992;12:6-7.
15. Martdis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002;109:920-927.
16. Jonas JB, Rreissig I, Degenring RF. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2002;240:782-783.
17. Antcliff RJ, Spalton DJ, Stanford MR, et al. Intravitreal triamcinolone for uveitic cystoid macular edema: An optical coherence tomography study. Ophthalmology 2001;108:765-772.
18. Yoshikawa K, Kotake S, Ichishi A, et al. Posterior sub-tenon injections of repository corticosteroid in uveitis patients with cystoid macular edema. Jpn J Ophthalmol 1995;39:71-76.
19. Okada AA, Wakabayashi T, Morimura Y, et al. Trans-Tenon's retrobulbar triamcinolone infusion for the treatment of uveitis. Br J Ophthalmol 2003;87:968-971.
20. Danis RP, Ciulla TA, Pratt LM, Anliker W. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 2000;20:244-250.
21. Jonas JB, Kreissig I, Hugger P, et al. Intravitreal triamcinolone acetonide for exudative age related macular degeneration. Br J Ophthalmol 2003;87:462-468.
22. Gillies MC, Simpson JM, Billson FA, et al. Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial. Arch Ophthalmol 2004;122:336-340.
23. Jonas JB, Kreissig I, Degenring RF. Retinal complications of intravitreal injections of triamcinolone acetonide. Graefes Arch Clin Exp Ophthalmol 2004;242:184-185.
24. Roth DB, Chieh J, Spirn MJ, et al. Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol 2003;121:1279-1282.
25. Dafflon ML, van Tran T, Crosier YG, Herbert CP. Posterior sub-tenon's steroid injections for the treatment of posterior ocular inflammation: indications, efficacy and side effects. Graefes Arch Clin Exp Ophthalmol 1999;237:289-295.
26. Levin DS, Han DP, Dev S, et al. Subtenon's depot corticosteroid injections in patients with a history of corticosteroid-induced intraocular pressure elevation. Am J Ophthalmol 2002;133:196-202.
27. Dobi ET, Puliafito CA, Destro M. A new model of experimental choroidal neovascularization in the rat. Arch Ophthalmol 1989;107:264-269.
28. Takehara Y, Kurokawa T, Kitamura T, et al. Suppression of laser-induced choroidal neovascularization by oral tranilast in the rat. Invest Ophthalmol Vis Sci 1999;40:459-466.
29. Kamizuru H, Kimura H, Yasukawa T, et al. Monoclonal antibody-mediated drug targeting to choroidal neovascularization in the rat. Invest Ophthalmol Vis Sci 2001;42:2664-2672.
30. Yanagi Y, Tamaki Y, Obata R, et al. Subconjunctival administration of bucillamine suppresses choroidal neovascularization in rat. Invest Ophthalmol Vis Sci 2002;43:3495-3499.
31. Murata T, He S, Hangai M, et al. Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization. Invest Ophthalmol Vis Sci 2000;41:2309-2317.
32. Grossniklaus HE, Ling JX, Wallace TM et al. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol Vis 2002;21: 119-126.
33. Frank RN, Aim RH, Eliott D, et al. Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. Am J Ophthalmol 1996;122:393-403.
34. Frank RN. Growth factors in age-related macular degeneration, pathogenic and therapeutic implications. Ophthalmic Res 1997;29:341-353.
35. Amin R, Puklin JE, Frank RN. Growth factor localization in choroidal neovascular membranes of age-related macular degeneration. Invest Ophthalmol Vis Sci 1994;35:3178-3188.
36. Kiffen M, Sharma HS, Mooy CM, et al. Increased expression of angiogenetic growth factors in age-related macular degeneration maculopathy. Br J Ophthalmol 1997;81:154-162.
37. Lopez PF, Sippy BD, Lambett HM, et al. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1996;37:855-868.
38. Blum S, Issbruker K, Willuweit A, et al. An inhibitory role of the phosphatidylinositol 3-kinase-signaling pathway in vascular endothelial growth factor-induced tissue factor expression. J Biol Chem 2001;276:33428-33434.
39. Blei F, Wilson EL, Mignatti P, et al. Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis. J Cell Physiol 1993;155:568-578.
40. Renner UP, Lohrer P, Schaaf L, et al. Transforming growth factor-beta stimulates vascular endothelial growth factor production by folliculostellate pituitary cells. Endocrinology 2002;143:3759-3765.
41. Edelman JL, Castro MR. Quantitative image analysis of laser-induced choroidal neovascularization in rat. Exp Eye Res 2000;71:523-533.
42. Ciulla TA, Criswell MH, Danis RP, et al. Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model. Arch Ophthalmol 2001;119:399-404.
43. Wang YS, Friedrichs U, Eichler W, et al. Inhibitory effects of triamcinolone acetonide on bFGF-induced migration and tube formation in choroidal microvascular endothelial cells. Graefes Arch Clin Exp Ophthalmol 2002;240:42-48.
44. Penn JS, Rajaratnam VS, Collier RJ, et al. The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci 2001; 42:283-290.
45. Clark AF, Mellon J, Li XY, et al. Inhibition of intraocular tumor growth by topical application of the angiostatic steroid anecortave acetate. Invest Ophthalmol Vis Sci 1999;40:2158-2162.
46. D'Amico DJ, Goldberg MF, Hudson H, et al. Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD): interim (month 6) analysis of clinical safety and efficacy. Retina 2003;23:14-23.
47. Weijtens O, van der Sluijs FA, Shoemaker RC, et al. Peribulbar corticosteroid injection: vitreal and serum concentrations after dexamethasone disodium phosphate injection. Am J Ophthalmol 1997;123:358-363.
48. Weijtens O, Shoemaker RC, Lentjes EG, et al. Dexamethasone concentration in the subretinal fluid after a subconjunctival injection, a peribulbar injection, or an oral dose. Ophthalmology 2000;107:1932-1938.
49. Geroski DH, Edelhauser HF. Transscleral drug delivery for posterior segment disease. Adv Drug Deliver Rev 2001;52: 37-48.
50. Freeman WR, Green RL, Smith RE. Echographic localization of corticosteroids after periocular injection. Am J Ophthalmol 1987;103:281-288.
51. Nozaki M, Okabe K, Okabe J, et al. Intraocular pharmacokinetics of triamcinolone acetonide after intravitreal and posterior sub-Tenon's capsule injections. Invest Ophthalmol Vis Sci 2004;45:E-Abstract 1920.